Anthony J. Schaeffer, MD ’68, has announced he intends to step down as chair of the Department of Urology. Dr. Schaeffer will continue his role as a distinguished member of the faculty, and will continue to serve as chair until a new one is appointed.
With its recent renewal, Feinberg’s Udall Center of Excellence for Parkinson’s Disease Research is one of 10 such centers funded by the National Institute of Neurological Disorders and Stroke.
More than 90 percent of adult social media users surveyed in a recent study would share their health records anonymously to help improve the care they and future patients receive, as well as to support medical research.
The discovery of an enzyme that is highly activated in cells from the joint fluid of rheumatoid arthritis patients may provide a new therapeutic target for the 1 million Americans affected by the disease.
Anis Contractor, PhD, associate professor in Physiology, recently published findings on what causes delays in synaptic and neuronal development in the cortex, hallmarks of fragile X syndrome, the most common known cause of autism.
Hossein Ardehali, MD, PhD, has discovered that doxorubicin, an effective and commonly used anticancer drug, is causing an accumulation of iron inside of a cell’s mitochondria, resulting in heart damage.
The third-annual luncheon celebrating Feinberg’s named professors serves as a way to thank and honor these faculty members for their accomplishments and contributions to science, education and research.
Northwestern Medicine scientists have developed a new prognostic tool for clinicians treating patients with large B-cell lymphoma. The predictive scale enhances the widely used International Prognostic Index.
Published in the Journal of Neuroscience, a discovery by Marco Martina, MD, PhD, associate professor in Physiology, sheds new light on the selective vulnerability of cell types in preclinical models of ataxia.
Variations in DNA sequence may have a significant impact on how humans respond to dengue virus. A group of scientists from Nicaragua, the University of California-Berkeley and Feinberg will seek to uncover genetic variants that make certain people more susceptible to life-threatening forms of the infection.